Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADVANCE trial of intracoronary ADRCs for STEMI
NL-OMON36077Phase 2Active, not recruiting
- Sponsor
- Plus Therapeutics
- Start
- May 2011
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2 trial of autologous adipose-derived stem/stromal cells in myocardial infarction (MI), sponsored by Plus Therapeutics. Primary endpoints: Myocardial infarct size, Left ventricular ejection fraction and 6 more. Started May 2011; status: active, not recruiting.
02
Drugs
autologous adipose-derived stem/stromal cells
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on NL-OMON36077.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON36077.